NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
21 hedge funds and large institutions have $875K invested in NKGen Biotech, Inc. Warrants in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 16 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
59% more capital invested
Capital invested by funds: $551K → $875K (+$323K)
40% less funds holding
Funds holding: 35 → 21 (-14)
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$63.8K |
| 2 |
ETH
Exos TFP Holdings
New York
|
+$27.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.33K |
| 4 |
CS
Clear Street
New York
|
+$66 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$25.1K |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$22.8K |
| 3 |
KL
KIM LLC
Wichita,
Kansas
|
-$21K |
| 4 |
6CM
683 Capital Management
New York
|
-$20K |
| 5 |
KC
Kepos Capital
New York
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KL
26
KIM LLC
Wichita,
Kansas
| – | -$21K | -92,040 | Closed |
|
|
KC
27
Kepos Capital
New York
| – | -$17K | -80,000 | Closed |
|
|
PAMP
28
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$12K | -60,000 | Closed |
|
|
CL
29
CSS LLC
Chicago,
Illinois
| – | -$7.52K | -37,600 | Closed |
|
|
FBCM
30
Fort Baker Capital Management
Larkspur,
California
| – | -$7.74K | -36,934 | Closed |
|
|
SC
31
Sculptor Capital
New York
| – | -$4.02K | -19,200 | Closed |
|
32
Walleye Capital
New York
| – | -$3.46K | -17,273 | Closed |
|
|
GCIA
33
Gabelli & Co Investment Advisers
Rye,
New York
| – | -$3.45K | -17,240 | Closed |
|
|
GF
34
Gabelli Funds
Rye,
New York
| – | -$3.44K | -17,221 | Closed |
|
|
FTUS
35
Flow Traders U.S.
New York
| – | -$2K | -12,524 | Closed |
|
36
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$2.39K | -11,935 | Closed |
|
|
SIA
37
Schechter Investment Advisors
Birmingham,
Michigan
| – | -$2.14K | -11,279 | Closed |
|
|
CCM
38
CAAS Capital Management
New York
| – | -$2K | -10,000 | Closed |
|
NKGNW Hedge Fund Activity: Q3 2023 in Review
21 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2023, worth a combined $875K — up 59% from $551K a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of NKGNW and 2 opened new positions — a net loss of 14 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $63.8K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $25.1K sold.
- 21 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2023, down from 35 in Q2 2023.
- Funds reported $875K of NKGen Biotech, Inc. Warrants stock for Q3 2023, up 59% quarter-over-quarter.
- 2 funds opened new NKGen Biotech, Inc. Warrants positions in Q3 2023 and 16 closed out, a net change of -14 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q3 2023 was Shaolin Capital Management, an estimated $63.8K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q3 2023 was Radcliffe Capital Management, an estimated $25.1K sold.
Based on aggregated 13F filings for Q3 2023.